Profile

About Paul

Paul Dent is a professor of biochemistry and molecular biology at the Virginia Commonwealth University School of Medicine in Richmond and holds the Universal Corporation Chair in cancer cell signaling at VCU Massey Comprehensive Cancer Center. Dent's laboratory studies signal transduction in tumor cells and how approved drugs, including kinase inhibitors such as neratinib, can be combined to trigger autophagy and kill cancer cells. Research from the group has carried several drug combinations from laboratory models into clinical trials at Massey, including pemetrexed with sorafenib in phase II testing. Dent has also served as vice chair of research in VCU's Department of Neurosurgery.
Published research

Publications

1 article

Research network

Co-authors

3 collaborators